Related references
Note: Only part of the references are listed.Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments
Ilaria Del Giudice et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC gene
Sarah E. Gibson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial
J. C. Strefford et al.
LEUKEMIA (2015)
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2015)
Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation
Arantza Onaindia et al.
HAEMATOLOGICA (2015)
Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations
John C. Riches et al.
BLOOD (2014)
Molecular Pathways: Targeting the Microenvironment in Chronic Lymphocytic Leukemia-Focus on the B-Cell Receptor
Elisa ten Hacken et al.
CLINICAL CANCER RESEARCH (2014)
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial
David G. Oscier et al.
BLOOD (2013)
CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes
David Gonzalez et al.
HAEMATOLOGICA (2013)
Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course
Natalie Put et al.
ANNALS OF HEMATOLOGY (2012)
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays
M. Ciccone et al.
LEUKEMIA (2012)
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Yair Herishanu et al.
BLOOD (2011)
Mutational Status of the TP53 Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial
David Gonzalez et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells
Carlo Calissano et al.
MOLECULAR MEDICINE (2011)
High rate of neoplastic cells with genetic abnormalities in proliferation centers of chronic lymphocytic leukemia
Zsofia Balogh et al.
LEUKEMIA & LYMPHOMA (2011)
Chronic lymphocytic leukaemia: prognostic value of lymphocyte morphological subtypes. A multivariate survival analysis in 146 patients
Teresa Vallespí et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia
Junia V. Melo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation
David Oscier et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
被撤回的出版物: Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (accelerated chronic lymphocytic leukemia) with aggressive clinical behavior (Retracted Article. See vol 95, pg 1620, 2010)
Eva Gine et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Proliferation centers in chronic lymphocytic leukemia: the niche where NF-κB activation takes place
B. Herreros et al.
LEUKEMIA (2010)
CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment
Piers E. M. Patten et al.
BLOOD (2008)
MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis
Yang O. Huh et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial
D. Catovsky et al.
LANCET (2007)